Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7-fluoro-3-methyl-8-(6-(3-piperidin-1-ylpropoxy)pyridin-3-yl)-1-propan-2-ylimidazo(4,5-c)quinolin-2-one
1. 2089288-03-7
2. Azd-1390
3. 7-fluoro-3-methyl-8-[6-(3-piperidin-1-ylpropoxy)pyridin-3-yl]-1-propan-2-ylimidazo[4,5-c]quinolin-2-one
4. Azd 1390
5. Unii-ci43qfe22o
6. Ci43qfe22o
7. 7-fluoro-1-isopropyl-3-methyl-8-(6-(3-(piperidin-1-yl)propoxy)pyridin-3-yl)-1,3-dihydro-2h-imidazo[4,5-c]quinolin-2-one
8. 2h-imidazo(4,5-c)quinolin-2-one, 7-fluoro-1,3-dihydro-3-methyl-1-(1-methylethyl)-8-(6-(3-(1-piperidinyl)propoxy)-3-pyridinyl)-
9. 7-fluoro-1-isopropyl-3-methyl-8-(-(3-(1-piperidinyl)propoxy)-3-pyridinyl)-1,3-dihydro-2himidazo(4,5-c)quinolin-2-one
10. 7-fluoro-1-isopropyl-3-methyl-8-(6-(3-(piperidin-1-yl)propoxy)pyridin-3-yl)-1h-imidazo[4,5-c]quinolin-2(3h)-one
11. 7-fluoro-3-methyl-8-(6-(3-piperidin-1-ylpropoxy)pyridin-3-yl)-1-propan-2-ylimidazo(4,5-c)quinolin-2-one
12. Chembl4594429
13. Schembl18631972
14. Atm Kinase Inhibitor Azd1390
15. C27h32fn5o2
16. Gtpl11277
17. Azd 1390 [who-dd]
18. Azd1390?
19. Ex-a2670
20. Bdbm50565800
21. Nsc803789
22. S8680
23. Zb1512
24. Akos037515647
25. Ccg-269518
26. Cs-8217
27. Nsc-803789
28. Ac-36283
29. Bs-15814
30. Da-50849
31. Hy-109566
32. D80599
33. 7-fluoro-1-isopropyl-3-methyl-8-{6-[3-(piperidin-1-yl)propoxy]pyridin-3-yl}imidazo[4,5-c]quinolin-2-one
| Molecular Weight | 477.6 g/mol |
|---|---|
| Molecular Formula | C27H32FN5O2 |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 61.8 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 720 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
91
PharmaCompass offers a list of AZD1390 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AZD1390 manufacturer or AZD1390 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AZD1390 manufacturer or AZD1390 supplier.
PharmaCompass also assists you with knowing the AZD1390 API Price utilized in the formulation of products. AZD1390 API Price is not always fixed or binding as the AZD1390 Price is obtained through a variety of data sources. The AZD1390 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AZD1390 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AZD1390, including repackagers and relabelers. The FDA regulates AZD1390 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AZD1390 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AZD1390 supplier is an individual or a company that provides AZD1390 active pharmaceutical ingredient (API) or AZD1390 finished formulations upon request. The AZD1390 suppliers may include AZD1390 API manufacturers, exporters, distributors and traders.
AZD1390 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AZD1390 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AZD1390 GMP manufacturer or AZD1390 GMP API supplier for your needs.
A AZD1390 CoA (Certificate of Analysis) is a formal document that attests to AZD1390's compliance with AZD1390 specifications and serves as a tool for batch-level quality control.
AZD1390 CoA mostly includes findings from lab analyses of a specific batch. For each AZD1390 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AZD1390 may be tested according to a variety of international standards, such as European Pharmacopoeia (AZD1390 EP), AZD1390 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AZD1390 USP).
